ArticleIrish journal of medical science2026
Beyond seropositivity: quantitative parietal cell antibody titers predict gastric intestinal metaplasia in a high helicobacter pylori prevalence setting.
Article in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAnti-gastric parietal cell antibody (APA) positivity is a recognized serological biomarker for autoimmune gastritis, but whether quantitative APA titer levels correlate with the severity of gastric intestinal metaplasia (GIM) in high Helicobacter pylori (H. pylori) prevalence settings remains unclear. This study aimed to evaluate the association between quantitative APA titer dilutions and histopathological GIM in a large endoscopic cohort.
methodsIn this retrospective cohort study, medical records of adult patients who underwent APA testing at a tertiary referral center between November 2017 and November 2019 were reviewed. Of 1,104 screened patients, 453 met inclusion criteria after excluding those with repeated testing or missing data; following exclusion of 118 patients without gastroscopy or adequate biopsy sampling, 335 patients who underwent standardized topographical gastric biopsy mapping constituted the definitive analysis cohort. Associations between APA status/titer dilutions and histopathological findings were assessed using chi-squared tests and multivariate logistic regression.
resultsGIM was present in 24.5% (n = 82) of the cohort. APA positivity was significantly associated with GIM (40.5% vs. 15.4% in APA-negative patients, p <0.001), with a titer-dependent dose-response relationship peaking at 50.0% in the 1:320 and >1:320 dilution subgroups. In multivariate analysis, each incremental step-up in APA titer dilution (OR 1.522, 95% CI 1.304-1.776) and advancing age (OR 1.043, 95% CI 1.021-1.066) independently predicted GIM, while active H. pylori infection was an independent negative predictor (OR 0.348, 95% CI 0.184-0.660).
conclusionQuantitative APA titers, rather than binary positivity, demonstrate a clear dose-response relationship with histopathological GIM. Titers of 1:320 or greater identify a clinically actionable threshold that may guide prioritization of endoscopic evaluation with standardized topographical biopsy mapping.
Indexed as
Identifiers
42873471What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.